Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2016

Nov 8, 2016

30786_dirs_2016-11-08_b1a4c050-7a89-49b5-8550-37552d9ad903.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-11-04

Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-04 Bio-Rad A Common Stock M 231 Acquired 3148 Direct
2016-11-07 Bio-Rad A Common Stock S 88 $165.62 Disposed 3060 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-04 Restricted Stock Units $0 M 231 Disposed Bio-Rad A Common Stock (231) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest in five equal annual installments beginning November 4, 2012.